Gossypol co-crystals and the use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S548000, C514S682000, C514S700000, C514S025000

Reexamination Certificate

active

07432300

ABSTRACT:
This invention relates to compositions comprising co-crystals of (−)-gossypol with a C1-8carboxylic acid or C1-8sulfonic acid which are useful as inhibitors of Bcl-2 family proteins. The invention also relates to the use of co-crystals of (−)-gossypol with a C1-8carboxylic acid or C1-8sulfonic acid for inducing apoptosis in cells and for sensitizing cells to the induction of apoptotic cell death.

REFERENCES:
patent: 3347885 (1967-10-01), Jones et al.
patent: 3364242 (1968-01-01), Johnson et al.
patent: 4297341 (1981-10-01), Waller et al.
patent: 4747979 (1988-05-01), Gimber et al.
patent: 4806568 (1989-02-01), Vander Jagt et al.
patent: 5026726 (1991-06-01), Jagt et al.
patent: 5059717 (1991-10-01), Ibragimov et al.
patent: 5077441 (1991-12-01), Kuk et al.
patent: 5112637 (1992-05-01), Hron, Sr. et al.
patent: 5260327 (1993-11-01), Kim et al.
patent: 5277909 (1994-01-01), Schmidt et al.
patent: 5385936 (1995-01-01), Flack et al.
patent: 5759837 (1998-06-01), Kahajda et al.
patent: 5780675 (1998-07-01), Royer et al.
patent: 6113397 (2000-09-01), Flack et al.
patent: 6114397 (2000-09-01), Flack et al.
patent: 6576660 (2003-06-01), Liao et al.
patent: 6608107 (2003-08-01), Wong et al.
patent: 6696484 (2004-02-01), Liao et al.
patent: 2002/0137801 (2002-09-01), Wong et al.
patent: 2003/0008924 (2003-01-01), Wang et al.
patent: 2003/0082101 (2003-05-01), Taylor et al.
patent: 2003/0119894 (2003-06-01), Murthy et al.
patent: 2005/0027000 (2005-02-01), Reed et al.
patent: 87105990 (1876-12-01), None
patent: 1033795 (1988-07-01), None
patent: 676360 (1988-12-01), None
patent: 1044455 (1990-08-01), None
patent: 1094392 (1994-11-01), None
patent: 87105990 (1987-12-01), None
patent: 1033795 (1989-12-01), None
patent: 1094392 (1994-11-01), None
patent: 1406919 (2001-09-01), None
patent: 1 917 341 (1969-04-01), None
patent: 19173741 (1969-04-01), None
patent: 0 651 636 (1993-07-01), None
patent: 2178204 (1973-03-01), None
patent: 01132542 (1969-04-01), None
patent: 01132542 (1987-11-01), None
patent: 001132542 (1987-11-01), None
patent: 2067111 (1996-09-01), None
patent: 322042 (1969-07-01), None
patent: 212245 (1973-10-01), None
patent: 322042 (1976-02-01), None
patent: 1351915 (1982-06-01), None
patent: 1351915 (1982-06-01), None
patent: 2067111 (1992-05-01), None
patent: WO 94/20497 (1994-09-01), None
patent: WO 96/04250 (1996-02-01), None
patent: WO 97/40015 (1997-10-01), None
patent: WO 02/41828 (2002-05-01), None
patent: WO 02/47673 (2002-06-01), None
V. Amberger, et al., Cancer Res., 58:149-158 (1998).
Wick et al, (W. Wick, et al., FEBS Lett., 440:419-424 (1998).
S. Mohanam et al., Cancer Res. 53:4143-4147 (1993).
P. Pedersen, et al., Cancer Res., 53:5158?5165 (1993).
Nuria Rubio, Lab Invest, 81:725-734 (2001).
Fernández et al., Cell Death Differ., 7:350-359 (2000).
J. Reed, Nature, 387:773-776 (1997).
S. Frisch and E. Ruoslahti, Curr. Opin. Cell Biol., 9:701-706 ((1997).
D. Del Bufalo, et al., FASEB J., 11:947?953 (1997).
Razakantoanina et al. Parasitol. Res., 86:665-668 (2000).
Dao et al. Bioorg. Med. Chem., 11:2001-2006 (2003).
Deck et al. J. Med. Chem., 34:3301-3305 (1991).
Przybylski et al. J. Mol. Structure, 611(1-3):193-201 (2002).
R.E. Royer et al., J. Med. Chem., 38:2427-2432 (1995).
R.E. Royer et al., Biologically active derivativse of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles:, J. Med. Chem., 29:1799-1801 (1986).
C.M. Venuti, J. Org. Chem., 46(15):3124-3127 (1981).
P.C. Meltzer et al., J. Org. Chem., 50(17):3121-3124 (1985).
R. Adams et al., J. Am. Chem. Soc., 60:2193-2204 (1938).
Le Blanc et al, “An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines”, Pharmacol. Res., 46:551-555 (2002).
Baumgrass et al., “Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol”, J. Biol. Chem., 276:47914-47921 (2001).
Shelley et al., “Structure-activity studies on gossypol in tumor cell lines,” Anticancer Drugs, 11:209-216 (2000).
Sonenberg et al., “Anti-fertility and othe ractions of gossypol analogues”, Contraception, 37:247-255, (1988).
Whaley et al, .“Monkey lactate dehydrogenase-C4 as a model for the interaction of enzymes with gossypol”, Contraception, 33:605-616 (1986).
Dorsett et al., “Letter: Antiviral activity of gossypol and apogossypol”, J. Pharm. Sci., 64:1073-1075 (1975).
Wu et al., “Synthesis and antifertility actions of gossypol derivatives and phenol aldehydes”, Yao Xue Xue Bao, 24:502-511 (1989).
Hoffer et al., “Antifertility, spermicidal and ultrastructural effects of gossypol and derivatives administered orally and by intratesticular injections”, Contraception, 37:301-331 (1988).
Guo et al., “Synthesis of mono-aldehyde gossypol and its analogues”, Yao Xue Xue Bao, 22:597-602 (1987).
Manmade et al., “Gossypol. Synthesis and in vitro spermicidal activity of isomeric hemigossypol derivatives”, Experientia, 39:1276-1277 (1983).
Dowd, Chirality, 15:486 (2003).
Ciesielska et al., Chem. Phys. Lett. 353:69 (2002).
Vermel et al., Antitumour Activity of Gossypol in Experiments on Transplanted Tumours 39-43 (1963).
Freedman et al., Chirality, 15:196 (2003).
J.C. Reed, Pharmacology, 41:501-553 (1997).
J.C. Reed et al., J. Cell Biochem., 6:23-32 (1996).
Z. Han et al., Cancer Res., 56:621-628 (1996).
S.W. Muchmore et al., Nature, 381:335-341 (1996).
A.M. Petros et al., Protein Sci., 9:2528-2534 (2000).
A.M. Petros et al., Proc. Natl. Acad. Sci. U.S.A., 98:3012-3017 (2001).
X.M. Yin et al., Nature, 369:321-323 (1994).
S.C. Cosulich et al., Curr. Biol., 7:913-920 (1997).
A. Sali et al., Structure, Function, and Genetics, 23:318-326 (1995).
A. Sali, Curr. Opin. Biotech., 6:437-451 (1995).
J.L. Wang et al., Cancer Res., 60:1498-1502 (2000).
J.L. Wang et al., Proc. Natl. Acad. Sci. U.S.A., 97:7124-7129 (2000).
Sattler et al., Science, 275:983-986 (1997).
B.R. Brooks et al., J. Comp. Chem., 4, 187-217 (1983).
P.V.R. Schleyer et al., CHARMM: The Energy Function and Its Parameterization with an Overview of the Program, in The Encyclopedia of Computational Chemistry, 1:271-277 eds., John Wiley & Sons, Chichester (1998).
S. Makino and I.D. Kuntz, J. Comput. Chem. 18:1812-1825 (1997).
I.J. Enyedy et al., J. Med. Chem., 44:313-4324 (2001).
Leschev, “Influence of the Extract of Eleutherococus senticosus on development of experimental pituitary adenomas in rats”, Institute of Oncology of the U.S.S.R. Academy of Medical Sciences, 60-67 (1966).
La Blanc et al., An in vitro study of inhibitory of gossypol, a cottonseed extract, in human carcinoma cell lines, Pharmacol. Res. 46(6):551-5 (2002).
Griffith et al., Bioenvision Successfully Completes Formulation Research to Develop Gossypol as a Novel Anti-Cancer Agent, Bioenvision News (2003).
Saydachmov et al., Uebekskii Khimicheski Zhumal (1):11-13 (1994).
Zakhidov et al., Modifying Cytogenetic Effects of Gossypol and Derivatives, Library National Institutes of Health (1994).
Yerukhimov, Treatment of Bladder Tumors With Gossipol And Ionol In Combination With Surgical Intervention, Issues in Oncology, XI (1966.
Kuznezova et al., Pharmacol. Toxicol., Boston Library Boston Spa (1979).
Zhong et al., National Library of Medicine, 2:159-161 (1982).
Zhang et al., Inhibitory effects (-)-gossypol on proliferation and keratinocyte growth factor expression in human breast epithelial cells, stromal cells, and adipocytes, American Association fro Cancer Research 38:218 (1997).
Zheng et al., Gossypol (GP) Stimulates Transforming Growth Factor Beta (TGF-â) Gene Expression in Human Breast Cancer Cell Line, The FASEB Journal 10:A757 (1996).
Zheng et al., Studies on the Resolution of Racemic Gossypol, ACTA Pharmaceutica Simica 25(6):430-434 (1990).
Adlakha et al., Inhibition of DNA Polymerase á And Ribonucleotide Reductase by By Gossypol, Proceedings of AACR 26:249:982 (1985).
Akhila et al., Biosynthesis of Gossypol inThespesia Populnea, Phytochemistry 33:335-340 (1993).
Ba

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gossypol co-crystals and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gossypol co-crystals and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gossypol co-crystals and the use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4015614

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.